AlTi Global (ALTI) vs abrdn Life Sciences Investors (HQL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
abrdn Life Sciences Investors (HQL) has outperformed AlTi Global (ALTI) over the past year, gaining 11.2% versus a loss of 22.3%. Over five years, HQL leads with a -15.0% price change compared with -72.2% for ALTI. abrdn Life Sciences Investors pays a dividend yielding 11.09%, while AlTi Global does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALTI | HQL |
|---|---|---|
| Share price | $2.74 | $17.22 |
| Market cap | $427.28M | — |
| 1-day change | -0.72% | -1.94% |
| YTD return | -40.52% | +4.65% |
| 1-year return | -22.25% | +11.21% |
| 5-year return | -72.23% | -15.00% |
| P/E ratio (TTM) | — | 2.59 |
| Forward P/E | 6.85 | — |
| EPS (TTM) | $-1.26 | $6.64 |
| Dividend yield | 0.00% | 11.09% |
| Annual dividend | $0.00 | $1.91 |
| 52-week high | $5.45 | $22.67 |
| 52-week low | $2.69 | $15.66 |
| Distance from 52-week high | -49.68% | -24.04% |
| Analyst consensus | none | — |
| Avg. price target upside | +228.47% | — |
| Average volume | 167.79K | 147.31K |
| Shares outstanding | 115.07M | — |
| Employees | 465 | — |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HQL has outperformed ALTI by 33.5 percentage points over the past year.
- abrdn Life Sciences Investors offers a meaningfully higher dividend yield (11.09% vs 0.00%).
About AlTi Global
ALTI stock →AlTi Global, Inc. provides wealth and asset management services in France, Hong Kong, Italy, Portugal, Singapore, Switzerland, the United Kingdom, the United States, the United Kingdom, and internationally.
Finance · Investment Managers · 465 employees
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
ALTI vs HQL FAQ
Which stock has performed better over the past year, ALTI or HQL?
HQL returned +11.21% over the past 12 months, compared with -22.25% for ALTI (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, AlTi Global or abrdn Life Sciences Investors?
abrdn Life Sciences Investors pays a dividend yielding 11.09%, while AlTi Global does not currently pay a regular dividend.
Are AlTi Global and abrdn Life Sciences Investors in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.